We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Topical Immunotherapy Lowers Risk of Skin Cancer

News   Mar 22, 2019 | Original story from Washington University School of Medicine in St. Louis

 
Topical Immunotherapy Lowers Risk of Skin Cancer

Washington University dermatologist Lynn Cornelius, MD, (left) conducts a skin exam with patient Robert Manchester. Manchester was a participant in a clinical trial testing the effectiveness of a topical immunotherapy against precancerous skin lesions called actinic keratoses, often found on sun-damaged skin. A three-year follow-up analysis suggests the therapy also reduces the risk that the precancerous lesions will progress to skin cancer. Credit: Washington University

 
 
Advertisement
 

RELATED ARTICLES

A Rooted Tree Might Be Key To Understanding Bacterial Evolution

News

Researchers have found a new way to interpret the evolution of bacteria. The findings demonstrate how integrating vertical descent and horizontal gene transfer can be used to infer the root of the bacterial tree and the nature of the last bacterial common ancestor.

READ MORE

Which Drugs Are Most Toxic to the Liver?

News

A new study provides insights on how hospitalized patients can develop liver injury from taking different drugs.

READ MORE

Determining Safe Drug Doses for Children

News

Aalto University researchers in collaboration with the pharmaceutical company Novartis have developed a method that makes better use of available data to help determine safe pediatric drug doses more quickly and with fewer observations.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE